[go: up one dir, main page]

HUP9900766A2 - Helicobacter pylorival kapcsolatos nukleinsav- és aminosavszekvenciák diagnosztikumokhoz és gyógyszerekhez - Google Patents

Helicobacter pylorival kapcsolatos nukleinsav- és aminosavszekvenciák diagnosztikumokhoz és gyógyszerekhez

Info

Publication number
HUP9900766A2
HUP9900766A2 HU9900766A HUP9900766A HUP9900766A2 HU P9900766 A2 HUP9900766 A2 HU P9900766A2 HU 9900766 A HU9900766 A HU 9900766A HU P9900766 A HUP9900766 A HU P9900766A HU P9900766 A2 HUP9900766 A2 HU P9900766A2
Authority
HU
Hungary
Prior art keywords
pylori
diagnostics
therapeutics
helicobacter pylori
amino acid
Prior art date
Application number
HU9900766A
Other languages
English (en)
Inventor
Thomas O. Berglindh
Björn L. Mellgärd
Douglas Smith
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of HUP9900766A2 publication Critical patent/HUP9900766A2/hu
Publication of HUP9900766A3 publication Critical patent/HUP9900766A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A találmány tárgyát Helicőbacter pylőriból származó új szekvenciák,példáűl pőlipeptideket - úgymint baktériűmők felszíni fehérjéit -kódőló és egyéb rőkőn szekvenciák, ezek termékei és felhasználásűkképezik. A találmány szerinti nűkleinsavak és peptidek alkalmazhatókH. pylőri és egyéb Helicőbacter fajők diagnősztikájában ésterápiájában, de felhasználhatók még H. pylőri és egyéb Helicőbacterfajők jelenlétének kiműtatására mintákban és H. pylőri életciklűsátakadályőzó vagy H. pylőri-fertőzést gátló vegyületek tesztelésére.Szintén a találmány tárgyát képezik H. pylőri-fertőzés kiműtatásáraalkalmas antitestek és nűkleinsavak, és a H. pylőri-fertőzésmegelőzésére vagy kezelésére szőlgáló vakcinakészítmények. ŕ
HU9900766A 1995-06-07 1996-06-06 Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics HUP9900766A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48703295A 1995-06-07 1995-06-07
US63040596A 1996-04-01 1996-04-01

Publications (2)

Publication Number Publication Date
HUP9900766A2 true HUP9900766A2 (hu) 1999-06-28
HUP9900766A3 HUP9900766A3 (en) 2002-08-28

Family

ID=27048874

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900766A HUP9900766A3 (en) 1995-06-07 1996-06-06 Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics

Country Status (14)

Country Link
EP (1) EP0842270A4 (hu)
JP (1) JPH11504220A (hu)
KR (1) KR19990022600A (hu)
CN (1) CN1186516A (hu)
BR (1) BR9609430A (hu)
CA (1) CA2223395A1 (hu)
CZ (1) CZ388697A3 (hu)
EE (1) EE9700373A (hu)
HU (1) HUP9900766A3 (hu)
IS (1) IS4630A (hu)
NZ (1) NZ311874A (hu)
PL (1) PL324826A1 (hu)
RU (1) RU98100081A (hu)
TR (1) TR199701538T1 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3007036A1 (en) * 2015-12-14 2017-06-22 Technische Universitat Munchen Helicobacter pylori vaccines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2098733A1 (en) * 1990-12-21 1992-06-22 Howard C. Krivan Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
AR003125A1 (es) * 1995-06-01 1998-07-08 Astra Ab Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la

Also Published As

Publication number Publication date
IS4630A (is) 1997-12-05
BR9609430A (pt) 1999-08-24
AU6327896A (en) 1996-12-30
CN1186516A (zh) 1998-07-01
PL324826A1 (en) 1998-06-22
HUP9900766A3 (en) 2002-08-28
AU710880B2 (en) 1999-09-30
KR19990022600A (ko) 1999-03-25
JPH11504220A (ja) 1999-04-20
RU98100081A (ru) 2005-11-27
CZ388697A3 (cs) 1998-08-12
TR199701538T1 (xx) 1998-03-21
EP0842270A4 (en) 1999-02-24
EE9700373A (et) 1998-06-15
EP0842270A1 (en) 1998-05-20
NZ311874A (en) 1999-11-29
CA2223395A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
Ambler [21] Carboxypeptidases A and B
Sanger The chemistry of insulin
Low et al. Complete amino acid sequence of bovine thymosin beta 4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations.
DK532284A (da) Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser
ES2013346A6 (es) Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles.
HU9202645D0 (en) Synthetic antigenes applicables for detecting antibodies of hepatitis c virus
GB8709803D0 (en) Treatment of crohn's disease &c
EA200000860A1 (ru) Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты)
Norén et al. Studies on a soluble dipeptidase from pig intestinal mucosa. I. Purification and specificity
Travis et al. Human pancreatic enzymes. Isolation and properties of a major form of chymotrypsin
Suzuki et al. Amino acid sequence of myoglobin from Aplysia kurodai
FR2660757B1 (fr) Procede d'identification ou de dosage de proteines et applications.
Goodman et al. Immunochemical studies on the poly-γ-D-glutamyl capsule of Bacillus anthracis. I. Characterization of the polypeptide and of the specificity of its reaction with rabbit antisera
ATE109512T1 (de) Expression und diagnose mit gag-kodierten peptiden, die mit antikörpern gegen lav immunologisch reaktiv sind.
Yoshida Micro method for determination of blocked NH2-terminal amino acids of protein: Application to identification of acetylserine of phosphoglycerate kinase and pyroglutamic acid of glucose 6-phosphate dehydrogenase
ATE4453T1 (de) Aminosaeure- und peptidester von leukoindoanilinen, verfahren zu deren herstellung sowie diese verbindungen enthaltende mittel zum nachweis proteolytischer enzyme.
HUP9900766A2 (hu) Helicobacter pylorival kapcsolatos nukleinsav- és aminosavszekvenciák diagnosztikumokhoz és gyógyszerekhez
EP1878797A3 (en) Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
AU1540795A (en) Diagnosis and treatment of infections due to streptococci and enterococci
Bridgen et al. Molecular heterogeneity of alkaline phosphatase
Conroy et al. Structural features and biologic properties of fragments obtained by limited proteolysis of C3
HU906421D0 (en) Process for testing analogous peptides of hiv
NO962596L (no) Nytt tumorsupressorgen
Tsao et al. Structure of ovotransferrin. I. Isolation and characterization of cyanogen bromide fragments. Reevaluation of the primary structure
DE69030655D1 (de) Verfahren zur herstellung eines rekombinanten proteins und seine verwendung in der bestimmungsmethode des afrikanischen schweinepestvirus